Free Cash Flow for Quest Diagnostics (DGX)
Free Cash Flow for Quest Diagnostics (DGX): headline value $1.33B · YoY +49.5%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingFree Cash FlowSwitch metric
Latest period
$1.33B
YoY change
+49.5%
5Y CAGR
-3.1%
Peak year (2021)
$1.83B
Latest annual
$1.36B
Free Cash Flow history chart for Quest Diagnostics (DGX) from 1996 to 2025
Free Cash Flow history table for Quest Diagnostics (DGX) from 1996 to 2025
| Fiscal year | Period ended | Reported | Free Cash Flow | YoY |
|---|---|---|---|---|
| 2025 | $1.36B | +49.5% | ||
| 2024 | $909.00M | +5.2% | ||
| 2023 | $864.00M | -34.2% | ||
| 2022 | $1.31B | -28.2% | ||
| 2021 | $1.83B | +15.3% | ||
| 2020 | $1.59B | +88.3% | ||
| 2019 | $843.00M | +3.2% | ||
| 2018 | $817.00M | -11.5% | ||
| 2017 | $923.00M | +18.9% | ||
| 2016 | $776.00M | +41.9% | ||
| 2015 | $547.00M | -13.2% | ||
| 2014 | $630.00M | +49.6% | ||
| 2013 | $421.00M | -58.1% | ||
| 2012 | $1.00B | +36.9% | ||
| 2011 | $734.00M | -19.6% | ||
| 2010 | $912.60M | +9.9% | ||
| 2009 | $830.50M | -2.3% | ||
| 2008 | $850.40M | +20.1% | ||
| 2007 | $707.82M | -6.7% | ||
| 2006 | $758.47M | +20.9% | ||
| 2005 | $627.31M | +0.7% | ||
| 2004 | $622.65M | +27.6% | ||
| 2003 | $488.16M | +10.6% | ||
| 2002 | $441.18M | +39.3% | ||
| 2001 | $316.82M | +25.2% | ||
| 2000 | $253.00M | -129.7% | ||
| 1999 | -$851.50M | -943.9% | ||
| 1998 | $100.90M | -22.1% | ||
| 1997 | $129.50M | -181.5% | ||
| 1996 | -$158.88M | — |
Free Cash Flow values are taken from Quest Diagnostics's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Quest Diagnostics (DGX) free cash flow totalled $1.36B – surged 49.5% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Quest Diagnostics free cash flow compounded at -3.1% per year, sustaining 2 straight years of year-over-year growth.
Quest Diagnostics free cash flow peaked at $1.83B in 2021; the latest annual figure is $1.36B in 2025 (25.7% below peak).
Across the available history, free cash flow reached its high of $1.83B in 2021 and its low of -$851.50M in 1999.
Quest Diagnostics (DGX) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $14.22B.
Quest Diagnostics Free Cash Flow by Year
Quest Diagnostics Free Cash Flow 2025: $1.36B
Quest Diagnostics free cash flow in 2025 was $1.36B, surged 49.5% from 2024.
Quest Diagnostics Free Cash Flow 2024: $909.00M
Quest Diagnostics free cash flow in 2024 was $909.00M, grew 5.2% from 2023.
Quest Diagnostics Free Cash Flow 2023: $864.00M
Quest Diagnostics free cash flow in 2023 was $864.00M, plunged 34.2% below 2022.
Quest Diagnostics Free Cash Flow 2022: $1.31B
Quest Diagnostics free cash flow in 2022 was $1.31B, declined 28.2% below 2021.
Quest Diagnostics Free Cash Flow 2021: $1.83B
Quest Diagnostics free cash flow in 2021 was $1.83B.
See more financial history for Quest Diagnostics (DGX).
Sector peers — Free Cash Flow
Companies in the same sector as Quest Diagnostics, ranked by their latest free cash flow.
| Company | Free Cash Flow | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $28.99B | Healthcare |
| Johnson & Johnson (JNJ) | $19.70B | Healthcare |
| AbbVie Inc. (ABBV) | $17.82B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $16.07B | Healthcare |
| Merck & Co., Inc. (MRK) | $12.36B | Healthcare |
| AstraZeneca PLC (AZN) | $11.77B | Healthcare |
| Eli Lilly and Company (LLY) | $8.97B | Healthcare |
| Amgen Inc. (AMGN) | $8.10B | Healthcare |
Frequently asked questions
What is Quest Diagnostics's free cash flow?
Latest reported free cash flow for Quest Diagnostics (DGX) is $1.33B (period ending March 31, 2026).
How has Quest Diagnostics free cash flow changed year-over-year?
Quest Diagnostics (DGX) free cash flow changed +49.5% year-over-year on the latest annual filing.
What is the long-term growth rate of Quest Diagnostics free cash flow?
Quest Diagnostics (DGX) free cash flow compound annual growth rate is -3.1% over the most recent 5 years available.
When did Quest Diagnostics free cash flow hit its highest annual value?
Quest Diagnostics free cash flow reached its highest annual value of $1.83B in 2021.
What was Quest Diagnostics free cash flow in 2024?
Quest Diagnostics (DGX) free cash flow in 2024 was $909.00M.
What was Quest Diagnostics free cash flow in 2025?
Quest Diagnostics (DGX) free cash flow in 2025 was $1.36B.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
DGX Overview
Company profile, financial tools, and key metrics
DGX Revenue Counter
Earns $357.62 every second. See per minute, hour, and day.
DGX Earnings Counter
Earns $32.47 per second net profit. See per minute, hour, and day.
DGX Economic Scale
Exceeds Monaco's GDP. Compare with world economies.
DGX What If Invested
What if you had invested $1,000? See historical returns from any date.
DGX How It Makes Money
Discover visual breakdown of $11.28B in revenue — where it comes from and where it goes.
DGX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
DGX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
DGX Daily Price Character
Steady · 50.6% historical win rate (green days). Streaks & record days.
DGX Buybacks
2.09% TTM buyback yield. Shareholder yield & SBC comparison.
DGX Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.
DGX Dividend Profile
Yield: 1.72%. Safety: 5/8. See full history.
DGX Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
DGX Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.